Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(7%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
7%
Ph not_applicable
9
64%
Ph phase_2
4
29%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
4(28.6%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
9(64.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(8)
Other(5)

Detailed Status

Completed8
unknown5
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (28.6%)
Phase 41 (7.1%)
N/A9 (64.3%)

Trials by Status

completed857%
unknown536%
active_not_recruiting17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
14